State Street Corp Blueprint Medicines Corp Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, State Street Corp holds 2,765,702 shares of BPMC stock, worth $262 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,765,702
Previous 2,379,884 16.21%
Holding current value
$262 Million
Previous $257 Million 0.31%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$84.1 - $120.5 $32.4 Million - $46.5 Million
385,818 Added 16.21%
2,765,702 $256 Million
Q2 2024

Aug 14, 2024
BUY
$85.18 - $108.78 $15.9 Million - $20.4 Million
187,182 Added 8.54%
2,379,884 $257 Million
Q1 2024

May 15, 2024
SELL
$73.17 - $99.79 $16.9 Million - $23.1 Million
-231,498 Reduced 9.55%
2,192,702 $208 Million
Q4 2023

Feb 14, 2024
SELL
$43.96 - $92.84 $8.85 Million - $18.7 Million
-201,427 Reduced 7.67%
2,424,200 $224 Million
Q3 2023

Nov 14, 2023
BUY
$46.9 - $66.0 $5.75 Million - $8.09 Million
122,634 Added 4.9%
2,625,627 $132 Million
Q2 2023

Aug 14, 2023
SELL
$42.2 - $66.37 $10.6 Million - $16.7 Million
-252,286 Reduced 9.16%
2,502,993 $158 Million
Q1 2023

May 15, 2023
SELL
$37.97 - $50.0 $3.02 Million - $3.98 Million
-79,642 Reduced 2.81%
2,755,279 $124 Million
Q4 2022

Feb 14, 2023
BUY
$41.06 - $66.48 $25.3 Million - $40.9 Million
615,123 Added 27.71%
2,834,921 $124 Million
Q3 2022

Nov 15, 2022
SELL
$49.93 - $77.7 $24.8 Million - $38.6 Million
-496,744 Reduced 18.29%
2,219,798 $146 Million
Q2 2022

Aug 15, 2022
BUY
$45.23 - $70.15 $20.3 Million - $31.5 Million
449,648 Added 19.84%
2,716,542 $137 Million
Q1 2022

May 16, 2022
BUY
$54.1 - $110.08 $29 Million - $58.9 Million
535,424 Added 30.92%
2,266,894 $145 Million
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $4.06 Million - $5 Million
43,086 Added 2.55%
1,731,470 $185 Million
Q3 2021

Nov 15, 2021
BUY
$80.98 - $109.47 $3.17 Million - $4.28 Million
39,138 Added 2.37%
1,688,384 $174 Million
Q2 2021

Aug 16, 2021
BUY
$82.78 - $101.0 $10.9 Million - $13.3 Million
131,741 Added 8.68%
1,649,246 $145 Million
Q1 2021

May 17, 2021
SELL
$90.71 - $108.28 $10.3 Million - $12.3 Million
-113,522 Reduced 6.96%
1,517,505 $148 Million
Q4 2020

Feb 16, 2021
SELL
$92.08 - $124.48 $16.8 Million - $22.7 Million
-182,261 Reduced 10.05%
1,631,027 $183 Million
Q3 2020

Nov 10, 2020
SELL
$66.45 - $92.7 $4.56 Million - $6.36 Million
-68,558 Reduced 3.64%
1,813,288 $168 Million
Q2 2020

Aug 14, 2020
SELL
$57.09 - $79.27 $4.45 Million - $6.18 Million
-77,995 Reduced 3.98%
1,881,846 $147 Million
Q1 2020

May 11, 2020
BUY
$48.11 - $82.22 $94.3 Million - $161 Million
1,959,841 New
1,959,841 $115 Million

Others Institutions Holding BPMC

# of Institutions
350
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.65B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email